Form 8-K - Current report:
SEC Accession No. 0001193125-22-294892
Filing Date
2022-11-30
Accepted
2022-11-30 07:01:12
Documents
21
Period of Report
2022-11-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d412417d8k.htm   iXBRL 8-K 24516
2 EX-99.1 d412417dex991.htm EX-99.1 11816
6 GRAPHIC g412417ex99_1s1g1.jpg GRAPHIC 478765
7 GRAPHIC g412417ex99_1s2g1.jpg GRAPHIC 1059418
8 GRAPHIC g412417ex99_1s3g1.jpg GRAPHIC 1037615
9 GRAPHIC g412417ex99_1s4g1.jpg GRAPHIC 368334
10 GRAPHIC g412417ex99_1s5g1.jpg GRAPHIC 730824
11 GRAPHIC g412417ex99_1s6g1.jpg GRAPHIC 730929
12 GRAPHIC g412417ex99_1s7g1.jpg GRAPHIC 732952
13 GRAPHIC g412417ex99_1s8g1.jpg GRAPHIC 682285
  Complete submission text file 0001193125-22-294892.txt   8176072

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neog-20221130.xsd EX-101.SCH 2848
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20221130_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20221130_pre.xml EX-101.PRE 10811
15 EXTRACTED XBRL INSTANCE DOCUMENT d412417d8k_htm.xml XML 3256
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 221434288
SIC: 2835 In Vitro & In Vivo Diagnostic Substances